Homozygosity for CCTG mutation in myotonic dystrophy type 2

61Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Myotonic dystrophy type 2 (DM2) is caused by a dominantly transmitted CCTG repeat expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene on chromosome 3q. DM2 patients with two mutant alleles have not been reported so far. In one large consanguineous family from Afghanistan, we found three homozygotes for the DM2 mutation. The oldest patient was clinically more severely affected, compared with the two younger homozygotes, but for the clinical course of symptoms all three homozygotes were within the range expected for heterozygotes. Further investigations, such as mutation repeat length, muscle histology, anti-muscleblind-like 1 stainings or brain imaging studies, at least at short-term observation, showed no differences between heterozygotes and homozygotes. Twenty of 24 children, aged 2-21 years, were available for clinical examination. None of these children have signs or symptoms of disease until the age of 18 years. Homozygosity for the DM2 expansion does not seem to alter the disease phenotype as compared with the heterozygous state.

Cite

CITATION STYLE

APA

Schoser, B. G. H., Kress, W., Walter, M. C., Halliger-Keller, B., Lochmüller, H., & Ricker, K. (2004). Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain, 127(8), 1868–1877. https://doi.org/10.1093/brain/awh210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free